MarketBeatWed, 13 May 2026 05:04:58 GMTBridgeBio Pharma Touts Attruby Blockbuster Path, 3 Potential Pipeline LaunchesBBIO+4.03%
Seeking AlphaWed, 13 May 2026 04:20:43 GMTBridgeBio Pharma, Inc. (BBIO) Presents at Bank of America Global Healthcare Conference 2026 TranscriptBBIO+4.03%
Seeking AlphaFri, 08 May 2026 15:31:17 GMTBridgeBio Pharma, Inc. (BBIO) Q1 2026 Earnings Call TranscriptBBIO+4.03%
Zacks Investment ResearchThu, 07 May 2026 22:26:10 GMTBridgeBio Pharma (BBIO) Reports Q1 Loss, Tops Revenue EstimatesBBIO+4.03%
Seeking AlphaWed, 29 Apr 2026 21:58:45 GMTBridgeBio: Attruby's Early Dominance Makes The Bull Case Hard To IgnoreBBIO+4.03%
Zacks Investment ResearchWed, 29 Apr 2026 15:01:44 GMTAmphastar Pharmaceuticals (AMPH) Expected to Beat Earnings Estimates: Should You Buy?BBIO+4.03%
Zacks Investment ResearchTue, 28 Apr 2026 15:09:20 GMTWill BridgeBio Pharma (BBIO) Report Negative Q1 Earnings? What You Should KnowBBIO+4.03%
Seeking AlphaThu, 23 Apr 2026 15:50:30 GMTBridgeBio Pharma: Genetic Disease Specialist Is Thriving - I'm Upgrading To BuyBBIO+4.03%
BenzingaThu, 12 Mar 2026 11:47:47 GMTBridgeBio Pharma Eyes First Treatment For Rare Muscle Disorder As Trial Data Shows Early ProgressBBIO+4.03%
Seeking AlphaWed, 11 Mar 2026 19:02:22 GMTBridgeBio Pharma, Inc. (BBIO) Presents at Barclays 28th Annual Global Healthcare Conference TranscriptBBIO+4.03%
Investors Business DailyTue, 10 Mar 2026 18:34:11 GMTWhy BridgeBio Leapfrogged Its 50-Day Line On Pfizer's Patent Shake-UpBBIO+4.03%
Zacks Investment ResearchWed, 25 Feb 2026 01:31:57 GMTBridgeBio Pharma (BBIO) Reports Q4 Loss, Beats Revenue EstimatesBBIO+4.03%
Seeking AlphaWed, 25 Feb 2026 00:27:51 GMTBridgeBio Pharma, Inc. (BBIO) Q4 2025 Earnings Call TranscriptBBIO+4.03%
